[Hong Kong, September 18, 2021] Recently, Mr. Kingsley Leung, Chairman of Great Bay Bio Holdings Limited (hereinafter referred to as “GBB”)

[HONG KONG, August 20, 2021] Recently, the 2021 Merck Greater Bay Area Innovation Bootcamp was held in Guangzhou. After comprehensive consideration and careful evaluation by Merck China and global experts from multiple dimensions such as technical foresig

[HONG KONG, August 16,2021] Recently, Great Bay Bio Holdings Limited (hereinafter referred to as“GBB”) was listed in SCMP’s AsiaSustainability Conference, expecting to rank as one of the TOP 10 mostpotential start-ups by the South China Morning Post (SCMP

[July 5, 2021 - Hong Kong] Great Bay Bio Holdings Limited (hereinafter referred to as “GBB”) announces that the company’s self-developed intelligent cell line stability prediction platform AlfaStaX, is officially launched. Given the easy accessibility an

[HONG KONG, May 8, 2021] Chairman of Great Bay Bio Limited, Mr. Kingsley Leung, was invited to participate in the "Youth Novation Start-up Cmpetition" hosted by Hong Kong Youth Development Alliance. Hong Kong Youth Development Alliance (YDAHK) is committ

[HONG KONG, April 29, 2021] Hong Kong Science and Technology Parks Corporation (HKSTP) and Federation of Hong Kong Industries (FHKI) today launched the joint R&D Hub programme to give visionary leaders and businesses from Hong Kong’s manufacturing industr

[Hong Kong, March 31, 2021] Great Bay Bio Holdings Limited (hereinafter referred to as “GBB”) is pleased to announce that the company’s self-developed AI-enabled cell culture media development platform, AlfaMedX®, is officially launched. AlfaMedX is crea

[Hong Kong, February 23, 2021] Great Bay Bio Holdings Limited (hereinafter referred to as "GBB") today announced it has completed a USD$3.8M Convertible Note Financing. Alibaba Hong Kong Entrepreneurs Fund (hereinafter referred to as "AEF") led the invest